BioCentury
ARTICLE | Financial News

BenevolentAI raises $115M

April 20, 2018 7:36 PM UTC

BenevolentAI (London, U.K.) raised $115 million on April 19 in a financing round that drew participation from 50 new and existing investors, including existing investor Woodford Investment Management. Most of the investors were U.S.-based.

BenevolentAI’s Judgment Augmented Cognition platform uses private and public genomic databases, as well as the scientific literature and patent databases, to tease out new drug targets and candidates in rare diseases. The company said its AI technology has shown it can reduce by four years early stage drug discovery (see BioCentury, Jan. 20, 2017)...

BCIQ Company Profiles

BenevolentAI S.A.